Search results
Roving blood cells that 'hunt and wipe out' cancer could stop disease spreading
The US Sun· 18 hours agoROVING white blood cells that hunt down cancer in different parts of the body could hold the key to...
EsoGuard shows high sensitivity in early precancer detection By Investing.com
Investing.com· 14 hours agoEsophageal DNA Test's efficiency in detecting esophageal precancer. The study, supported by the...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 1 day agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options ...
Chesapeake firefighters attack an increased cancer risk with early detection screening
13 News, WVEC Hampton Roads· 4 days agoChesapeake firefighters are getting screened for esophageal cancer with the EsoGuard test. The...
...Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital...
FOX 4 Kansas City· 3 days ago("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove ...
Hematemesis (Vomiting Blood)
Health via Yahoo News· 6 days ago...to bleeding in the lower GI tract and often caused by conditions such as hemorrhoids, anal fissures, inflammatory bowel disease (IBD), or colorectal ...
Remembering Sonja Christopher! Here's Every 'Survivor' Contestant Who Has Died Since Competing
Parade via AOL· 5 days agoUnfortunately, cancer showed back up in Sunday's life after her time on the island, as she was...
Nanobiotix S.A. to Post FY2025 Earnings of $1.07 Per Share, Leerink Partnrs Forecasts (NASDAQ:NBTX)
ETF DAILY NEWS· 4 days agoNanobiotix S.A. (NASDAQ:NBTX – Free Report) – Leerink Partnrs raised their FY2025 earnings per share (EPS) estimates for Nanobiotix in a research note issued on Thursday, April 25th. Leerink ...
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business...
WKBN 27 Youngstown· 22 hours agoElevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range ...
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board
CBS 47 Fresno· 23 hours agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize ...
